Adjuvant Pazopanib Does Not PROTECT Against Recurrence of High-Risk, Initially Localized Renal Cell Cancer but Does Provide Novel Insights.
作者信息
Stewart Grant D, Leibovich Bradley C, Negrier Sylvie, Figlin Robert A
机构信息
Grant D. Stewart, University of Cambridge, Cambridge, United Kingdom; Bradley C. Leibovich, Mayo Clinic, Rochester, MN; Sylvie Negrier, University of Lyon, Lyon, France; and Robert A. Figlin, Cedars-Sinai Medical Center, Los Angeles, CA.
出版信息
J Clin Oncol. 2017 Dec 10;35(35):3895-3897. doi: 10.1200/JCO.2017.75.4242. Epub 2017 Oct 25.
PMID:29068785
Abstract
摘要
Zotero 插件